Table 1 Baseline characteristics in all patients infected with SFTSV.
Variables | Recovered patients (n = 30) | Deceased patients (n = 11) | P value |
|---|---|---|---|
Age, years | 63.6 (56.2–71.1) | 65.4 (62.7–71.3) | 0.494 |
Males, % | 18 (58.1%) | 6 (60.0%) | 0.914 |
Duration, daysa | 19.0 (16.0–24.3) | 10.0 (8.0–11.0) | 1.80 × 10−5 |
SFTSV, IU/mLb | 1.66 × 104 (5.60 × 102−2.28 × 105) | 3.67 × 106 (4.01 × 105−3.83 × 107) | 4.961 × 10−4 |
Complete blood count | |||
WBC, ×109/ L | 3.46 (1.90–4.35) | 2.75 (1.68–7.17) | 0.976 |
Neutrophil, ×109/L | 1.87 (1.20–3.81) | 1.15 (0.73–5.15) | 0.564 |
Lymphocyte, ×109/L | 0.60 (0.46–1.04) | 0.76 (0.50–1.67) | 0.387 |
RBC, ×1012/L | 4.12 (3.88–4.47) | 3.61 (3.42–4.26) | 0.029 |
Hemoglobin, g/L | 129.0 (118.6–140.0) | 120.0 (104.8–141.0) | 0.274 |
Platelet, ×109/L | 43.0 (22.0–55.0) | 35.0 (14.0–45.8) | 0.261 |
CRP, mg/L | 3.60 (2.19–18.30) | 8.96 (6.07–11.84) | 0.351 |
Coagulation | |||
PT, s | 11.60 (10.60–12.20) | 12.10 (11.63–12.70) | 0.164 |
APTT, s | 37.20 (33.00–44.40) | 63.50 (47.40–66.75) | 2.368 × 10−4 |
Liver function | |||
ALT, U/L | 88.0 (47.0–147.0) | 142.00 (108.5–191.5) | 0.033 |
AST, U/L | 221.0 (108.0–486.0) | 825.00 (459.0–1299.5) | 1.132 × 10−3 |
TBIL, μmol/L | 10.20 (7.80–13.40) | 10.30 (9.40–22.80) | 0.315 |
Renal function | |||
BUN, mmol/L | 5.04 (3.70–6.72) | 7.95 (4.83–12.55) | 0.022 |
Creatinine, μmol/L | 68.0 (62.60–84.40) | 90.00 (70.50–145.80) | 0.041 |